Published in Circulation on June 17, 2003
Venous Thromboembolism in Myotonic Dystrophy Type 1 (DM1-VTE) | NCT03424460
Pulmonary embolism in hospital practice. BMJ (2006) 2.27
Air travel and venous thromboembolism: a systematic review. J Gen Intern Med (2007) 2.21
Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am (2007) 2.17
Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008. Am J Obstet Gynecol (2012) 2.03
The diagnosis and treatment of acute pulmonary embolism. Dtsch Arztebl Int (2010) 1.96
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ (2011) 1.96
Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol (2007) 1.80
Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis. Circulation (2015) 1.66
Venous thromboembolism. BMJ (2006) 1.52
Factors that predict thrombosis in relatives of patients with venous thromboembolism. Blood (2014) 1.45
Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis (2010) 1.26
Routine chemoprophylaxis for deep venous thrombosis in Indian patients: Is it really justified? Indian J Orthop (2007) 1.24
Incidence and risk factors for development of venous thromboembolism in Indian patients undergoing major orthopaedic surgery: results of a prospective study. Postgrad Med J (2006) 1.15
Deep vein thrombosis: a clinical review. J Blood Med (2011) 1.15
A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Genet Epidemiol (2013) 1.12
Epoetin-beta treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events. Br J Cancer (2009) 1.09
Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. Thromb Haemost (2013) 1.08
Common genetic risk factors for venous thrombosis in the Chinese population. Am J Hum Genet (2013) 1.01
Health disparities among Latinas aging with disabilities. Fam Community Health (2008) 0.99
Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J (2015) 0.98
Learning to predict post-hospitalization VTE risk from EHR data. AMIA Annu Symp Proc (2012) 0.98
Clinical update on pulmonary embolism. Arch Med Sci (2013) 0.96
Snoring and the risk of obstructive sleep apnea in patients with pulmonary embolism. Sleep (2010) 0.96
Ambient particulate matter air pollution and venous thromboembolism in the Women's Health Initiative Hormone Therapy trials. Environ Health Perspect (2010) 0.96
Sudden death caused by acute pulmonary embolism after laparoscopic total extraperitoneal inguinal hernia repair: a case report and literature review. Hernia (2017) 0.96
Comparison of Dabigatran vs. Warfarin in Acute Vnous Thromboemboly: Systematic Review. Iran J Pharm Res (2016) 0.95
What do prostate cancer patients die of? Oncologist (2011) 0.95
Treatment options for venous thromboembolism: lessons learnt from clinical trials. Thromb J (2014) 0.95
Long-term tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study. J Fam Plann Reprod Health Care (2012) 0.92
Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition? Hepatol Int (2010) 0.89
Venous thromboembolism: classification, risk factors, diagnosis, and management. ISRN Hematol (2011) 0.89
Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors. Neurol Res (2012) 0.88
Risk of venous thromboembolism in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 0.87
Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery. Crit Care (2014) 0.87
Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteers. PLoS One (2011) 0.87
Thromboembolic prophylaxis in total joint arthroplasty. Thrombosis (2012) 0.87
Venous thromboembolism and cancer risk among elderly adults in the United States. Cancer Epidemiol Biomarkers Prev (2014) 0.86
Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis. PLoS One (2013) 0.86
Benefit vs. Risk of a Permanent Inferior Vena Cava Filter in Pulmonary Embolism with Anticoagulation Contraindication. Maedica (Buchar) (2013) 0.86
Activated protein C accelerates venous thrombus resolution through heme oxygenase-1 induction. J Thromb Haemost (2014) 0.85
Venous thromboembolism in hematopoietic stem cell transplant recipients. Bone Marrow Transplant (2015) 0.84
Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas. Neuro Oncol (2014) 0.84
Symptomatic venous thromboembolism in Asian colorectal cancer surgery patients. World J Surg (2011) 0.84
ExPeKT--Exploring prevention and knowledge of venous thromboembolism: a two-stage, mixed-method study protocol. BMJ Open (2013) 0.84
Thrombotic risk assessment questionary helps increase the use of thromboprophylaxis for patients with pelvic and acetabular fractures. Indian J Orthop (2012) 0.84
Venous thromboembolic disease in colorectal patients. Clin Colon Rectal Surg (2009) 0.83
Race, ABO blood group, and venous thromboembolism risk: not black and white. Transfusion (2012) 0.83
The geko™ electro-stimulation device for venous thromboembolism prophylaxis: a NICE medical technology guidance. Appl Health Econ Health Policy (2015) 0.83
Implementing thrombosis guidelines in cancer patients: a review. Rambam Maimonides Med J (2014) 0.83
Instructive ECG series in massive bilateral pulmonary embolism. Heart (2005) 0.83
Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial. BMC Cardiovasc Disord (2007) 0.83
Musculoskeletal and neuromuscular interventions: a physical approach to cystic fibrosis. J R Soc Med (2005) 0.83
Obesity, poor muscle strength, and venous thromboembolism in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci (2010) 0.82
In patients with idiopathic venous thrombosis, interleukin-10 is decreased and related to endothelial dysfunction. Heart Vessels (2011) 0.82
Does thromboprophylaxis prevent venous thromboembolism after major orthopedic surgery? J Bras Pneumol (2013) 0.82
Impact of comorbidity on risk of venous thromboembolism in patients with breast cancer: a Danish population-based cohort study. BMJ Open (2014) 0.81
Acute lung failure. Semin Respir Crit Care Med (2011) 0.81
The Association of Coronary Artery Calcium With Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging (2016) 0.81
Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients? Vasc Health Risk Manag (2009) 0.81
Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs. Am J Med (2014) 0.80
Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.80
Eliminating Health Care Disparities With Mandatory Clinical Decision Support: The Venous Thromboembolism (VTE) Example. Med Care (2015) 0.79
The prevalence of Factor V Leiden, prothrombin G20210A, MTHFR C677T and MTHFR A1298C mutations in healthy Turkish population. Hippokratia (2016) 0.79
Ambulation after deep vein thrombosis: a systematic review. Physiother Can (2009) 0.79
Rate of venous thromboembolism among surgical patients in Australian hospitals: a multicentre retrospective cohort study. BMJ Open (2014) 0.79
Incidence of venous thromboembolic complications in instrumental spinal surgeries with preoperative chemoprophylaxis. J Korean Neurosurg Soc (2015) 0.79
Estimated Prevalence of Venous Thromboembolism in Iran: Prophylaxis Still an Unmet Challenge. Tanaffos (2015) 0.79
Temperature and blood flow distribution in the human leg during passive heat stress. J Appl Physiol (1985) (2016) 0.79
Epidemiology, clinical profile and treatment patterns of venous thromboembolism in cancer patients in Taiwan: a population-based study. BMC Cancer (2015) 0.79
Combined cis-regulator elements as important mechanism affecting FXII plasma levels. Thromb Res (2009) 0.79
Hypoxia Induces a Prothrombotic State Independently of the Physical Activity. PLoS One (2015) 0.79
Efficacy and Safety of High-Dose Subcutaneous Unfractionated Heparin Prophylaxis for the Prevention of Venous Thromboembolism in Obese Hospitalized Patients. Hosp Pharm (2016) 0.78
Cardiac BNP gene delivery prolongs survival in aged spontaneously hypertensive rats with overt hypertensive heart disease. Aging (Albany NY) (2014) 0.78
Prolonged use of thromboprophylaxis may not be necessary in laparoscopic colorectal surgery. Int J Colorectal Dis (2011) 0.78
IgG-class anti-PF4/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics. BMC Musculoskelet Disord (2011) 0.78
The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants. Vasc Health Risk Manag (2009) 0.78
Hematologic genetic testing in high-risk patients before knee arthroplasty: a pilot study. Clin Orthop Relat Res (2011) 0.78
Venous thromboembolism in medical patients during hospitalisation and 3 months after hospitalisation: a prospective observational study. BMJ Open (2016) 0.78
Cu(2+)-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy. Int J Nanomedicine (2015) 0.78
Venous thromboembolic prophylaxis for hip fractures. Osteoporos Int (2010) 0.78
Postcesarean thromboprophylaxis with two different regimens of bemiparin. Obstet Gynecol Int (2011) 0.78
Residents case report: deep vein thrombosis in a high school baseball pitcher following ulnar collateral ligament (ucl) reconstruction. Int J Sports Phys Ther (2013) 0.77
Incidental pulmonary embolism detected by routine CT in patients with cancer. Cancer Imaging (2005) 0.77
Underlying cause discovered for a prior idiopathic AMI. BMJ Case Rep (2011) 0.77
Clustering patterns of comorbidities associated with in-hospital death in hospitalizations of US adults with venous thromboembolism. Int J Med Sci (2013) 0.77
Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism. Thromb Res (2015) 0.77
Pulmonary embolism related to amisulpride treatment: a case report. Case Rep Psychiatry (2013) 0.77
Prevalence and Risk Factors of Deep Vein Thrombosis in Patients Undergoing Lumbar Interbody Fusion Surgery: A Single-Center Cross-Sectional Study. Medicine (Baltimore) (2015) 0.77
Advances in the diagnosis and treatment of acute pulmonary embolism. F1000 Med Rep (2012) 0.76
Inherited trombophilic states and pulmonary embolism. J Res Med Sci (2009) 0.75
Practice guidelines and clinical risk assessment models: is it time to reform? BMC Med Inform Decis Mak (2011) 0.75
New anticoagulants emerge, how can we use them for acute pulmonary embolism? J Thorac Dis (2012) 0.75
Pneumothorax complicating pulmonary embolism after combined spinal epidural anesthesia in a chronic smoker with open femur fracture. J Anaesthesiol Clin Pharmacol (2011) 0.75
Office-based anesthesia. Semin Plast Surg (2007) 0.75
Venous thromboembolism following colorectal surgery for suspected or confirmed malignancy. Thrombosis (2011) 0.75
A chewable low-dose oral contraceptive: a new birth control option? Patient Prefer Adherence (2012) 0.75
Comparison of Chemical and Mechanical Prophylaxis of Venous Thromboembolism in Nonsurgical Mechanically Ventilated Patients. Thrombosis (2015) 0.75
Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 3.41
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Ann Intern Med (2015) 2.63
Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation (2009) 2.60
A 30-year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes (2009) 2.53
Predicting deep venous thrombosis in pregnancy: out in "LEFt" field? Ann Intern Med (2009) 2.26
A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). Am J Cardiol (2004) 2.10
Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial. Ann Intern Med (2013) 2.09
Incidence and hospital death rates associated with heart failure: a community-wide perspective. Am J Med (2005) 1.90
Long-term survival after heart failure: a contemporary population-based perspective. Arch Intern Med (2007) 1.81
Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med (2013) 1.79
Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest (2010) 1.67
Venous thromboembolism in patients with symptomatic atherosclerosis. Thromb Haemost (2011) 1.52
Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes: findings from a Global Registry of Acute Coronary Events. Circulation (2005) 1.42
30-year trends in heart failure in patients hospitalized with acute myocardial infarction. Am J Cardiol (2011) 1.39
Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry. Eur Heart J (2005) 1.39
Trends in prehospital delay in patients with acute myocardial infarction (from the Worcester Heart Attack Study). Am J Cardiol (2008) 1.36
Twenty-year trends in the incidence of stroke complicating acute myocardial infarction: Worcester Heart Attack Study. Arch Intern Med (2008) 1.32
Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 1.31
Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol (2005) 1.19
Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol (2009) 1.18
Changing trends in the long-term prognosis of patients with acute myocardial infarction: a population-based perspective. Am Heart J (2006) 1.14
Formatting modifications in GRADE evidence profiles improved guideline panelists comprehension and accessibility to information. A randomized trial. J Clin Epidemiol (2012) 1.11
Trends in mortality attributed to heart failure in Worcester, Massachusetts, 1992 to 2001. Am J Cardiol (2005) 1.10
Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions. Am J Med (2010) 1.07
Cognitive impairment and self-care in heart failure. Clin Epidemiol (2013) 1.05
Clinical features, treatment practices, and hospital and long-term outcomes of older patients hospitalized with decompensated heart failure: The Worcester Heart Failure Study. J Am Geriatr Soc (2009) 1.05
Use of disease-modifying therapies in patients hospitalized with heart failure: a population-based perspective. Am J Med (2007) 1.03
Epidemiology of decompensated heart failure in a single community in the northeastern United States. Am J Cardiol (2009) 1.02
Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry. Coron Artery Dis (2010) 1.00
Long-term trends in short-term outcomes in acute myocardial infarction. Am J Med (2011) 0.99
Contemporary trends in evidence-based treatment for acute myocardial infarction. Am J Med (2010) 0.97
Anatomic distribution of deep vein thrombosis in pregnancy. CMAJ (2010) 0.96
Delays in seeking medical care in hospitalized patients with decompensated heart failure. Am J Med (2008) 0.95
Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective. Arch Intern Med (2007) 0.95
Age and sex differences and 20-year trends (1986 to 2005) in prehospital delay in patients hospitalized with acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2010) 0.94
Development of a novel, multilayered presentation format for clinical practice guidelines. Chest (2015) 0.93
Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction. Am J Cardiol (2011) 0.92
Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes. Am Heart J (2010) 0.90
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes. Am Heart J (2002) 0.87
Symptom presentation in patients hospitalized with acute heart failure. Clin Cardiol (2010) 0.87
Trends in the medical management of patients with heart failure. J Clin Med Res (2013) 0.86
Use of nonpharmacologic treatment approaches in patients with heart failure. Int J Cardiol (2006) 0.86
Delayed hospital presentation in acute decompensated heart failure: clinical and patient reported factors. Heart Lung (2013) 0.86
Thirty-year trends (1975-2005) in the magnitude and hospital death rates associated with complete heart block in patients with acute myocardial infarction: a population-based perspective. Am Heart J (2008) 0.85
Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial. Implement Sci (2013) 0.84
Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol (2008) 0.84
Retracted Long-term trends (1986-2003) in the use of coronary reperfusion strategies in patients hospitalized with acute myocardial infarction in central Massachusetts. Int J Cardiol (2008) 0.83
Venous thromboembolism in patients with chronic obstructive pulmonary disease. Am J Med (2012) 0.83
Venous thromboembolism in heart failure: preventable deaths during and after hospitalization. Am J Med (2011) 0.82
Barriers and potential solutions toward optimal prophylaxis against deep vein thrombosis for hospitalized medical patients: a survey of healthcare professionals. J Hosp Med (2011) 0.82
Venous thromboembolism in patients with diabetes mellitus. Am J Med (2012) 0.82
A community-wide perspective into changing trends in the utilization of diagnostic and interventional procedures in patients hospitalized with acute myocardial infarction. Am Heart J (2007) 0.82
Culprit vessel only vs immediate complete revascularization in patients with acute ST-segment elevation myocardial infarction: systematic review and meta-analysis. Clin Cardiol (2014) 0.82
Changes over time in the use of aspirin in patients hospitalized with acute myocardial infarction (1975 to 1997): a population-based perspective. Am Heart J (2002) 0.81
Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes. Am Heart J (2009) 0.81
Venous thromboembolism in patients with reduced estimated GFR: a population-based perspective. Am J Kidney Dis (2011) 0.81
Circadian variations in acute myocardial infarction: patients or health care delivery? J Am Coll Cardiol (2003) 0.81
Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor. J Thromb Thrombolysis (2003) 0.80
Long-term trends in the use of coronary reperfusion strategies in acute myocardial infarction: a community-wide perspective. J Thromb Thrombolysis (2007) 0.80
Thirty-year trends (1975-2005) in the magnitude, patient characteristics, and hospital outcomes of patients with acute myocardial infarction complicated by ventricular fibrillation. Am J Cardiol (2008) 0.80
Multidecade-long trends (1986-2005) in the utilization of coronary reperfusion and revascularization treatment strategies in patients hospitalized with acute myocardial infarction: a community-wide perspective. Coron Artery Dis (2009) 0.79
Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation. Can J Cardiol (2012) 0.79
Decompensated heart failure in the setting of kidney dysfunction: a community-wide perspective. Nephron Clin Pract (2007) 0.79
Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition. Am Heart J (2002) 0.78
A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era... Am Heart J (2005) 0.78
Survival after hospital discharge for ST-segment elevation and non-ST-segment elevation acute myocardial infarction: a population-based study. Clin Epidemiol (2013) 0.78
Venous thromboembolism in patients with prior stroke. Clin Appl Thromb Hemost (2013) 0.77
Changing trends (1986-2003) in the use of lipid lowering medication in patients hospitalized with acute myocardial infarction: a community-based perspective. Int J Cardiol (2008) 0.77
Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review. J Thromb Thrombolysis (2013) 0.77
Thromboepidemiology: identifying patients with heritable risk for thrombin-mediated thromboembolic events. Am Heart J (2005) 0.77
Therapies for acute heart failure in patients with reduced kidney function: a community-based perspective. Am J Kidney Dis (2008) 0.77
Temporal patterns of lipid testing and statin therapy in acute coronary syndrome patients (from the Canadian GRACE Experience). Am J Cardiol (2012) 0.77
Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance. J Thromb Thrombolysis (2002) 0.76
Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events). Am J Cardiol (2005) 0.76
Hospitalization for hemorrhage among warfarin recipients prescribed amiodarone. Am J Cardiol (2013) 0.76
Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort. Anesthesiology (2016) 0.76
ACP journal club. Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events. Ann Intern Med (2015) 0.75
Response. Chest (2013) 0.75
Recurrence after unprovoked venous thromboembolism. BMJ (2011) 0.75
When guidelines collide... Am Heart J (2004) 0.75
Use of heparins in Non-ST-elevation acute coronary syndromes. Am J Med (2007) 0.75
Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitor. J Thromb Thrombolysis (2004) 0.75
Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist. Thromb Haemost (2004) 0.75
Incidence of deep vein thrombosis in erysipelas or cellulitis of the lower extremities. Int J Dermatol (2012) 0.75
Major bleeding after PCI. Where is our crystal ball? Eur Heart J (2007) 0.75